Manual therapy for improving oral and swallowing function in head and neck cancer survivors

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial aims to evaluate the effectiveness and safety of a manual therapy program on oral opening, swallowing function, and upper quarter mobility in survivors of head and neck cancer. Participants will be randomly assigned to either a manual therapy group or a control group receiving motor control exercises. The intervention consists of three sessions per week over six weeks, totaling 18 appointments, with assessments conducted at baseline, post-intervention, and six weeks after treatment completion. The study focuses on improving quality of life, pain management, and functionality in this patient population.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* individuals with HNC
* individuals over 18 years of age
* individuals who have undergone oncological surgery of the head and neck and/or radiotherapy
* having finished oncological medical treatment between 3 and 36 months before inclusion
* having a medical diagnosis of trismus and/or TMD and/or cervical or shoulder dysfunction
* Spanish native speakers

Exclusion Criteria:

* sequelae of previous stroke
* structural instability and/or osteoporosis of the cervical spine, spondylosis, cervical herniated discs
* active osteoradionecrosis or open wounds (fistulas, soft tissue necrosis) in the anatomical treatment area
* tracheostomized individuals
* metastasis or active cancer
* refuse to participate.

Where it's running

• Barbara Burgos Mansilla
  Temuco, Cautin, Chile Recruiting
• Universidad de La Frontera
  Temuco, Cautin, Chile Recruiting

Study contacts

• Principal investigator: Barbara Burgos, PhD — Universidad de La Frontera
• Study coordinator: Barbara Burgos, PhD
• Email: barbara.burgos@ufrontera.cl
• Phone: +56991358814

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Using Botox to treat jaw stiffness in head and neck cancer patients after radiation

  This study is testing if Botox injections can help head and neck cancer patients who have jaw stiffness after radiation therapy feel better and open their mouths more easily.

  Recruiting Phase 4 National Taiwan University Hospital · Taipei · NCT06734598

• Assessing early physical therapy for jaw movement issues in head and neck cancer patients

  This study is testing if starting physical therapy early can help prevent jaw movement problems in head and neck cancer patients undergoing radiation treatment.

  Recruiting University of Alberta · Edmonton, Alberta · NCT06531083

• Phenotype-based Pain Guidance for Head and Neck Cancer-Related Pain (pilot)

  This pilot test sees if tailoring pain treatment to a patient’s pain type can reduce head and neck cancer pain in adults who haven’t started cancer treatment yet.

  Recruiting Phase 2 Shaukat Khanum Memorial Cancer Hospital & Research Centre · Lahore, Punjab Province · NCT07919444

• Airway ultrasound in head and neck cancer patients

  This observational study tests whether neck ultrasound measurements of the airway match CT measurements in adults with maxillofacial cancer undergoing surgery with anesthesia.

  Recruiting at 2 sites University Hospital Dubrava · Zagreb, City of Zagreb and 1 other locations · NCT07910149

• Safe use of metformin and naproxen to help prevent cancer in people with Fanconi anemia

  This study tests whether metformin and naproxen can lower the chance of cancer developing in adults with Fanconi anemia.

  Recruiting at 2 sites Phase 1 Rockefeller University · Minneapolis, Minnesota and 1 other locations · NCT07901959

• Iparomlimab and Tuvonralimab With Cetuximab Before Surgery in Resectable Oral Cancer

  In this phase 2 study, patients with locally advanced, resectable oral squamous cell carcinoma will receive a combination of iparomlimab, tuvonralimab, and cetuximab before surgery to see if the treatment is safe and can shrink tumors.

  Recruiting Phase 2 Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University · Shanghai, Shanghai Municipality · NCT07882888

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.